| Name | Title | Contact Details |
|---|
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn`s experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea.
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health.
Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services.